Pengxiang Li
- Family Practice top 1%
- Medication Adherence and Compliance 15
- Geriatrics and Gerontology top 5%
- Economics and Econometrics top 2%
- Health Systems, Economic Evaluations, Quality of Life 16
- Healthcare Policy and Management 15
- Pharmaceutical Economics and Policy 15
- Economic and Financial Impacts of Cancer 8
- Cancer Research top 10%
-
- Primary Care and Health Outcomes 6
- Global Health Care Issues 5
-
- Schizophrenia research and treatment 5
- Co-authors
- Jalpa A. DoshiAmy R. PettitJohn A. SchneiderMichelle M. KimKatrina ArmstrongMarcia M. WardHairong HuoRobert L. Ohsfeldt
- Partner nations
- United StatesChinaFrance
In The Last Decade
Pengxiang Li
63 papers receiving 1.3k citations
Peers
Comparison fields: 5 of 114
- Family Practice 212
- Geriatrics and Gerontology 85
- Economics and Econometrics 558
- Health Information Management 58
- Cancer Research 172
Countries citing papers authored by Pengxiang Li
This map shows the geographic impact of Pengxiang Li's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Pengxiang Li with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Pengxiang Li more than expected).
Fields of papers citing papers by Pengxiang Li
This network shows the impact of papers produced by Pengxiang Li. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Pengxiang Li. The network helps show where Pengxiang Li may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Pengxiang Li, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2023 | 9 | |
| 4 | 2020 | 64 | |
| 5 | 2020 | 9 | |
| 6 | 2019 | 19 | |
| 7 | 2019 | 6 | |
| 8 | 2018 | 8 | |
| 9 | Synchronized prescription refills and medication adherence: a retrospective claims analysis. | 2017 | 12 |
| 10 | 2017 | 7 | |
| 11 | Impact of Medicare Advantage Prescription Drug Plan Star Ratings on Enrollment: Before and After Implementation of Quality-Related Bonus Payments in 2012 | 2016 | 0 |
| 12 | Impact of cost sharing on specialty drug utilization and outcomes: a review of the evidence and future directions. | 2016 | 30 |
| 13 | High cost sharing and specialty drug initiation under Medicare Part D: a case study in patients with newly diagnosed chronic myeloid leukemia. | 2016 | 35 |
| 14 | 2015 | 2 | |
| 15 | 2015 | 13 | |
| 16 | 2015 | 1 | |
| 17 | 2010 | 15 | |
| 18 | 2009 | 20 | |
| 19 | 2008 | 6 | |
| 20 | 2008 | 25 |
About Pengxiang Li
Pengxiang Li is a scholar working on Family Practice, Economics and Econometrics and Geriatrics and Gerontology, having authored 70 papers that have together received 1.4k indexed citations. Recurring topics across this work include Health Systems, Economic Evaluations, Quality of Life (16 papers), Medication Adherence and Compliance (15 papers), Healthcare Policy and Management (15 papers), Pharmaceutical Economics and Policy (15 papers), Economic and Financial Impacts of Cancer (8 papers), Primary Care and Health Outcomes (6 papers), Global Health Care Issues (5 papers) and Schizophrenia research and treatment (5 papers). The work is most often cited by research in Family Practice (212 citations), Geriatrics and Gerontology (85 citations) and Economics and Econometrics (558 citations). Pengxiang Li has collaborated with scholars based in United States, China and France. Frequent co-authors include Jalpa A. Doshi, Amy R. Pettit, John A. Schneider, Michelle M. Kim, Katrina Armstrong, Marcia M. Ward, Hairong Huo, Robert L. Ohsfeldt, Marissa Blum and Yu‐Ning Wong. Their work appears in journals such as JAMA, Journal of Clinical Oncology and Blood.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.